Related Experiment Videos
Lymph node metastasis in breast cancer: common prognostic markers lack predictive value
1Department of Surgery, Henry Ford Hospital, Detroit, Michigan 48202-2689, USA.
Annals of Surgical Oncology
|November 27, 1998
Summary
Biologic tumor markers are not reliable predictors of breast cancer lymph node metastasis. Primary tumor size and pathology are the only significant predictors, highlighting the need for direct lymph node evaluation.
Area of Science:
- Oncology
- Breast Cancer Research
- Surgical Pathology
Background:
- Assessing axillary lymph node status is critical in breast cancer management.
- Predicting lymph node metastasis based on primary tumor characteristics remains a challenge.
Purpose of the Study:
- To investigate if routine biologic tumor markers can predict lymph node metastasis in invasive breast cancer.
- To identify predictors of axillary lymph node metastasis based on primary tumor biology.
Main Methods:
- Analysis of prospectively gathered data from 851 invasive breast cancer patients.
- Inclusion of pathology, tumor site, receptor status, DNA index, S-phase fraction, nuclear grade, and intraductal component.
- Univariate and multivariate analyses to determine predictors of lymph node metastasis (any and ≥10).
Main Results:
- Primary tumor size and pathology were the only independent predictors of lymph node metastasis.
- Tumor size and estrogen receptor (ER)-negative status predicted 10 or more metastases.
- These factors explained less than 20% of lymph node metastases, indicating limited predictive power.
Conclusions:
- Biologic tumor markers are unreliable for predicting lymph node metastasis in most breast cancers.
- Direct pathologic evaluation of lymph nodes remains essential.
- Alternative methods like sentinel lymph node biopsy are recommended for accurate staging.